LFST (LifeStance Health Group) Capital Expenditure: $-43.96 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LFST LifeStance Health Group Inc LFST
51 GF Score
Price $12.73
GF Value $8.63
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is LifeStance Health Group Capital Expenditure?

LifeStance Health Group LFST -0.78% 51 Capital Expenditure is $-43.96 Mil as of Jun. 2026. GuruFocus rates LFST with a GF Score™ of 51/100 and a GF Value™ of $8.63 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

LifeStance Health Group's cash flow for capital expenditures for the three months ended in Jun. 2026 was $-12 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2026 was $-43.96 Mil.

LifeStance Health Group Capital Expenditure Historical Data

* Premium members only.

The historical data trend for LifeStance Health Group's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LifeStance Health Group Capital Expenditure Chart

LifeStance Health Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Capital Expenditure
Get a 7-Day Free Trial -94.49 -79.26 -40.52 -21.57 -36.13

LifeStance Health Group Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.76 -10.29 -10.91 -10.77 -11.99
LFST
51GF Score
LifeStance Health Group Inc LFST
Capital Expenditure is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LifeStance Health Group Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-43.96 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Capital Expenditure →
What does a Capital Expenditure of $-43.96 Mil mean?
LifeStance Health Group (LFST) has a Capital Expenditure of $-43.96 Mil as of Jun. 2026. Capital Expenditures represent the company's purchases of property, plant, equipment and other long-term fixed assets. View historical data for LifeStance Health Group.
Is LifeStance Health Group's Capital Expenditure too high?
LifeStance Health Group's current Capital Expenditure is $-43.96 Mil. Overall, LifeStance Health Group has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Capital Expenditure compare to CON and OPCH?
LifeStance Health Group's Capital Expenditure of $-43.96 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capital Expenditure for a Healthcare Providers & Services company?
A good Capital Expenditure depends on the Healthcare Providers & Services industry context. However, Capital Expenditure should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capital Expenditure mean?
A high Capital Expenditure can signal that a stock is expensive relative to its fundamentals. Capital Expenditures represent the company's purchases of property, plant, equipment and other long-term fixed assets. View historical data for LifeStance Health Group. LifeStance Health Group's current Capital Expenditure is $-43.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Significantly Overvalued. The stock's GF Value™ is $8.63, compared to a current price of $12.73 — trading 47.5% above its estimated fair value. The current Capital Expenditure is $-43.96 Mil. LifeStance Health Group's overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capital Expenditure calculated?
Capital Expenditure is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Capital Expenditure is $-43.96 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LifeStance Health Group (LFST) Overvalued in 2026?

Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued. The current stock price of $12.73 is trading 47.5% above its estimated GF Value™ of $8.63. GuruFocus considers LifeStance Health Group to be Significantly Overvalued.

Key valuation signals for LFST:

  • Capital Expenditure: $-43.96 Mil
  • GF Value™: $8.63 vs. price of $12.73 (47.5% above fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

LifeStance Health Group Business Description

Address 4800 North Scottsdale Road, Suite 2500, Scottsdale, AZ, USA, 85251
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
51GF Score

Get the complete analysis for LFST

Capital Expenditure is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.73
Price
$8.63
GF Value